Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
---|---|---|---|---|---|---|---|---|
Revenue | 1.58B | 501.22M | 663.18M | 285.98M | 456.74M | 221.99M | 116.80M | 24.86M |
Cost of Revenue | 403.48M | 306.85M | 282.44M | 107.43M | 61.66M | 52.15M | 31.06M | 9.24M |
Gross Profit | 1.18B | 194.37M | 380.74M | 178.54M | 395.08M | 169.84M | 85.74M | 15.62M |
Operating Expenses | 379.42M | 25.09M | 25.68M | -107.47M | -43.24M | 18.65M | 12.90M | 6.64M |
Selling, General & Admin | 379.42M | 25.09M | 25.68M | 23.44M | 19.03M | 13.32M | 10.29M | 6.23M |
Research & Development | N/A | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Operating Expenses | N/A | -109.19M | 158.85M | -130.91M | -62.27M | 5.33M | 2.62M | 416.00K |
Operating Income | 1.20B | 783.67M | 856.63M | 546.38M | 625.30M | 274.78M | 125.86M | 19.33M |
Other Expenses / Income | -392.00M | 306.85M | -84.39M | 10.62M | -147.47M | -48.61M | -12.75M | 4.07M |
Before Tax Income | 810.68M | 476.13M | 637.50M | 393.44M | 499.99M | 203.34M | 103.90M | 16.99M |
Income Tax Expenses | 17.36M | 9.77M | 12.61M | 5.71M | 1.98M | 1.09M | 158.00K | 352.00K |
Net Income | 793.31M | 466.36M | 624.88M | 387.74M | 498.00M | 202.24M | 103.74M | 16.64M |
Interest Expenses | 410.59M | 307.54M | 219.13M | 152.94M | 125.31M | 71.44M | 21.96M | 2.34M |
Basic Shares Outstanding | 390.10M | 394.01M | 392.30M | 388.65M | 324.63M | 135.73M | 67.08M | 383.69M |
Diluted Shares Outstanding | 390.10M | 394.01M | 392.30M | 388.65M | 324.63M | 135.73M | 67.80M | 383.69M |
EBITDA | N/A | 543.44M | 830.15M | 539.77M | 417.44M | 389.09M | 180.71M | N/A |
EBITDA Margin | 0.00% | 108.42% | 125.18% | 188.75% | 91.40% | 175.27% | 154.71% | 0.00% |
EBIT | 1.22B | 783.67M | 856.63M | 546.38M | 625.30M | 274.78M | 125.86M | 19.33M |
EBIT Margin | 77.19% | 156.35% | 129.17% | 191.06% | 136.90% | 123.78% | 107.76% | 77.78% |
Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |